arrow
I

Isabela Pazotti Daher

universidade de sao paulo
H指数:4
被引数:41

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice

AddaS03和聚I:C佐剂对BALB/c小鼠RBD疫苗接种后抗体滴度和Th1偏向T细胞反应的协同效应

Vaccine
IF3.5
2026-08-220
OA
An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication

一种针对SARS-CoV-2的创新性鼻用纳米疫苗可诱导系统性及上呼吸道免疫,控制病毒复制

2026-03-040
OAAI
Electrochemical Detection of SARS-CoV-2 in Saliva Using ZnO Nanorods Functionalized with Gold-Conjugated Antireceptor-Binding Domain Antibodies

利用与抗受体结合域抗体金标记的ZnO纳米棒电化学检测唾液中的SARS-CoV-2

2025-10-280
OAAI
Electrochemical immunosensor for antibody recognition against SARS-CoV-2 B-cell epitope: impact of RBD mutations on antigen–antibody binding

电化学免疫传感器用于抗SARS-CoV-2 B细胞表位的抗体识别:RBD突变对抗原-抗体结合的影响

2025-07-260
PRE
Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants

小鼠抗体4B1D3对SARS-CoV-2变种表现出广泛的交叉反应性和中和活性。

2025-07-210
PRE
Neutralizing antibody responses after a two-dose regimen with BNT162b2 CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants

巴西使用BNT162b2、CoronaVac或ChAdOx1-S两剂接种方案后的中和抗体反应:对SARS-CoV-2奥密克戎变异株的中和差异

2025-07-010
PRE
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals (vol 15, 1396603, 2024)

来自地方性冠状病毒的Anti-RBD IgG抗体,并不能保护暴露但未感染SARS-CoV-2的人群免受感染(vol 15, 1396603, 2024)

2025-04-110
OA
Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein

重组rbd-igg嵌合蛋白预防接种后增强的免疫原性和对SARS-CoV-2的保护作用

2024-03-271
OAAI
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
2023-01-058
OAAI